Back to articles
Comparative guide · 6 min read

Saffron vs 5-HTP for mood — the RCT-backed extract vs the precursor

Updated 2026-05-13 · Reviewed by SupplementScore editors · No sponsorships

Both are pitched as "natural antidepressants," and both have some serotonergic mechanism — but the trial evidence is wildly different. Saffron (Crocus sativus stigma extract) has a dozen-plus modern RCTs in mild-to-moderate depression, multiple meta-analyses, and a clean safety profile at trial doses. 5-HTP has a thin and methodologically weak trial literature, real interaction risk with prescription serotonergic drugs, and a historical contamination scare (eosinophilia-myalgia syndrome) that still shapes regulatory caution. Saffron is the better pick for almost everyone considering one of these.

Quick verdict

GoalBetter choiceWhy
Mild-to-moderate depression (unmedicated)SaffronMultiple RCTs and meta-analyses show effects comparable to low-dose SSRI / TCA in trial settings.
Premenstrual mood symptomsSaffron30 mg/day RCT showed reduced PMS symptoms vs placebo at two cycles.
SSRI-induced sexual dysfunction (adjunct)SaffronSmall RCTs show improvement in arousal and orgasm in users on SSRIs (with prescriber oversight).
Acute "I need to feel better tonight"NeitherBoth take 2–6 weeks to show effects in trials.
Use alongside an SSRI / SNRI / MAOI / triptanSaffron (cautiously) — never 5-HTP without prescriber5-HTP increases serotonin syndrome risk; saffron is lower-risk in interaction terms.
Cost per monthRoughly equalTrial-grade saffron ($15–35/mo) vs 5-HTP ($10–25/mo). Cost difference is small.

How each one works

Saffron — crocin and safranal, multiple mechanisms

Saffron extract (typically standardised to ≥2% safranal or to crocin content) is the dried stigma of Crocus sativus. Animal and mechanistic work shows it modulates serotonin, dopamine, and norepinephrine reuptake, has anti-inflammatory effects, and increases BDNF expression. The clinical story is less mechanistic and more trial-driven: ~30 mg/day of standardised extract has produced consistent improvements on the Hamilton Depression Rating Scale (HDRS) and Beck Depression Inventory across studies in Iran, Australia, and the US, with effect sizes broadly comparable to low-dose fluoxetine or imipramine in head-to-head trials.

5-HTP — direct serotonin precursor

5-Hydroxytryptophan is the intermediate between tryptophan and serotonin. It bypasses the rate-limiting tryptophan hydroxylase step, so oral 5-HTP can raise central serotonin synthesis. Trials in depression are old, small, often unblinded, and were summarised in a Cochrane review as low-quality. There's a separate small literature in fibromyalgia (where serotonin precursors have plausible relevance to pain modulation) but again the trials are weak.

Serotonin syndrome risk with 5-HTP. Do not combine 5-HTP with SSRIs, SNRIs, MAOIs, triptans, tramadol, dextromethorphan, linezolid, lithium, St John's wort, or other serotonergic agents without prescriber supervision. Symptoms range from agitation, sweating, and tremor to life-threatening hyperthermia. Saffron has a much lower interaction profile but caution and prescriber awareness are still warranted on any serotonergic prescription.

Evidence quality — the real divide

Saffron has multiple methodologically reasonable double-blind, placebo-controlled and active-comparator RCTs and several systematic reviews / meta-analyses. The effect sizes in meta-analysis are moderate (Hedges' g ≈ 0.8 vs placebo across pooled trials), and head-to-head trials vs fluoxetine and imipramine generally found non-inferiority at the doses studied. 5-HTP has a Cochrane review (Shaw 2002) that found only two trials of acceptable methodological quality, with insufficient evidence to recommend routine use.

Dose, form, and timing

Saffron: 28–30 mg/day of a standardised extract (Affron, Satiereal, or equivalent), split AM/PM or single daily dose. Allow 2–6 weeks for full effect. Choose products with standardised safranal/crocin content and third-party testing.

5-HTP: 50–200 mg/day in divided doses, often taken in the evening. Enteric-coated forms reduce GI side effects. Should not be combined with serotonergic medications.

Safety profile

Saffron: well-tolerated at trial doses. Mild GI effects, headache, and reduced appetite in some users. Avoid very high doses (>1.5 g/day) — historical toxicity at very large amounts. Pregnancy: avoid (traditional use as emmenagogue / abortifacient in folk medicine; safety data inadequate).

5-HTP: nausea is the most common side effect. Theoretical link to peripheral L-amino acid decarboxylase activation; "Peak X" contamination caused an EMS outbreak in 1989 attributed to tryptophan precursors, prompting ongoing regulatory caution. Modern reputable supplements are not contaminated but third-party testing matters more here than elsewhere.

Practical rule. For mild-to-moderate low mood in an otherwise healthy unmedicated adult, saffron 28–30 mg/day standardised extract has substantially better trial evidence than 5-HTP and a cleaner interaction profile. Neither replaces evaluation for depression by a qualified clinician, and severe, persistent, or worsening symptoms warrant medical assessment rather than supplement-first management.

When 5-HTP might still be worth considering

The narrow case for 5-HTP: an unmedicated adult with mild low mood and reasonable expectations who has tried saffron without benefit, and who has no serotonergic prescription or contraindication. Even then, the evidence base is weaker than for saffron and stronger than for many other "mood" supplements (rhodiola, SAMe in specific indications). For depression alongside a sleep complaint, melatonin or magnesium glycinate (sleep) plus saffron (mood) is a more evidence-aligned stack than 5-HTP-as-everything.

Who should pick each

Pick saffron if: you want the better-evidenced of the two, you are on any serotonergic medication, you are postmenopausal or premenstrual and want a single supplement that covers mood plus PMS, you want the smaller interaction footprint.

Pick 5-HTP if: you've already tried saffron without benefit, you have no serotonergic medication on board, you have a sleep complaint that fits the evening-dose profile.

What we'd actually buy

Saffron extract 28 mg/day from a brand that publishes safranal/crocin standardisation and a third-party COA, for a 6–8 week trial. If no benefit after 8 weeks at trial dose, discontinue and pursue clinical assessment rather than dose escalation.

Sources

Read more: